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www.jacctctabstracts2014.com SATURDAY, SEPTEMBER 13, 2014, 5:00 PM–7:00 PMThe number of retrograde procedures were exponentially increasing during the last 2
years and were associated with high success, low major complications rates and good
outcome.
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Background: Little is known of the potential effects of successful revascularization of
chronic total occlusions (CTO) on left ventricular (LV) function. LV global longitu-
dinal strain (GLS) is a more sensitive measure of LV mechanics than LV ejection
fraction (EF). GLS can be assessed with two-dimensional speckle-tracking echocar-
diography (2DSTE) and is signiﬁcantly related to long-term clinical outcome in pa-
tients with chronic ischemic heart disease. This study was conducted to investigate the
impact of revascularization of CTO on LV function using LV GLS.
Methods: A total of 70 patients (668.9 years, 59 males, LVEF 5212%) with CTO
who underwent percutaneous coronary intervention (PCI) were included in this study.
Echocardiography was performed before the procedure and 9 month after the pro-
cedure with conventional assessment including LV end-diastolic and end-systolic
volume (LVEDV, LVESV), LVEF, and with 2DSTE analysis of GLS.
Results: Successful PCI (TIMI 3 ﬂow) was obtained in 60 patients (86%). There were
no stent thromboses during follow-up. GLS showed a signiﬁcant improvement 9
months after successful PCI (⊿¼2.12.8%; P< 0.01), whereas that in failed PCI
group did not change signiﬁcantly (⊿¼-0.94.1%; P¼0.49). ⊿GLS is greater in
successful PCI group than failed group (p¼0.005). LVEF, LVEDV and LVESV did
not change during follow-up in both successful and failed groups.Conclusions: Successful PCI for CTO improves left ventricular function assessed by
LV GLS. This improvement may be associated with the long-term beneﬁcial effect of
PCI for CTO lesions.
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Background: Chronic total occlusion (CTO) in the non-infarcted-related artery was
reported to worsen immediate clinical outcome in patients with acute myocardial
infarction (AMI). However, the prognosis of such patients with preserved left ven-
tricular function has not been clariﬁed yet. Our objectives were to evaluate whether the
presence of CTO solely contributes to worsen the prognosis in the patients with well-
preserved heart function after primary PCI.
Methods:Weretrospectively evaluated 370 consecutiveAMIpatientswith preserved left
ventricular pump function (left ventricular ejection fraction; LVEF >40%) who under-
went primary percutaneous coronary intervention (PCI) in our hospital between January
2008 and December 2012. AMI patients complicated with cardiopulmonary arrest out of
the hospital (n¼33), having the left main trunk culprit lesion (n¼23), and diagnosed after
24 hours from the symptoms onset (n¼7) were excluded from total study population.
Results: Of those, 26 (7.0%) patients had CTO lesions in a non-infarct related artery
(CTO patients). The LVEF estimated by echocardiography after primary PCI was similar
between CTO patients and patients without CTO lesion (non CTO patients) (53.58.6%
vs 57.79.4%; p¼0.06). CTO patients were signiﬁcantly more likely to be associated
with cardiogenic shock (23.1% vs 9.0%; p< 0.05) and to require intraaortic balloon
pumping (57.7% vs 13.1%; p< 0.001) and an extracorporeal membrane oxygenator
(7.7% vs 1.7%; p< 0.05) for hemodynamic support during PCI when compared withJACC Vol 64/11/Suppl B j September 13–17, 2014 j TCT Abstracts/Conon CTO patients. Cardiogenic shock and 30-days mortality were signiﬁcantly higher in
CTO patients as compared with non CTO patients (23.1% vs 9.0%; p< 0.05, 7.7% vs
0.9%; p< 0.05, respectively). By multivariate analysis, 30-days survival as well as
cardiogenic shock were independently associated with CTO (odds ratio [OR] 9.44, 95%
CI 1.51-59.26, p¼0.04, OR 3.03, 95% CI 1.13-8.10, p¼0.03, respectively).
Conclusions: In patients with AMI, even if their LVEF were preserved, CTO was
strongly associated with cardiogenic shock and high mortality.
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Background: Chronic total occlusion (CTO) percutaneous coronary intervention
(PCI) has evolved signiﬁcantly with the development of the ’hybrid’ approach. We
sought to review the outcomes after CTO-PCI in a multi-centre registry of ’hybrid’
trained operators in the United Kingdom (UK).
Methods: The UK Hybrid CTO registry is a multicenter registry comprising
consecutive patients undergoing PCI for CTO in 7 UK centres (10 operators). Pro-
cedural and 30 day outcomes were deﬁned for 991 patients (1187 CTOs), representing
all procedures performed at these centres between January 2012 and April 2014. All
continuous variables are presented as mean  standard deviation, and categorical
variables as percentages.
Results: Mean age of the cohort was 64.410.2 years. 74% were male. 26% of pa-
tients had a prior PCI attempt and 22% had undergone previous surgical revascular-
ization. Lesion complexity was high (average J-CTO score of 2.5+-1.4, 71% had a
J-CTO score of 2 or higher). Average lesion length was 28 21mm. Initial procedural
strategy was antegrade wire escalation (AWE) in 62%, antegrade dissection re-entry
(ADR) in 12%, retrograde wiring (RW) in 12% and retrograde dissection re-entry
(RDR) in 14%. The average number of strategies utilized was 1.5  0.7. The ﬁnal
strategy was AWE (47%), ADR (22%), RW (8%) and RDR (23%). Technical success
rate per procedure (TIMI 3 ﬂow and < 30% stenosis) was 76%. Per patient success
rates (including repeat attempts) was 89%, highlighting the value of an ‘investment’
procedure. Mean wire crossing time was 4138 minutes. Procedural time was short
(mean 10846minutes) with 66% of cases completed in less than 2 hours. Contrast
(mean 305121ml) and radiation (mean ﬂuoroscopy time 4123minutes, mean dose-
area product 142059895cGycm2) exposure were relatively low. The in-hospital
major adverse cardiac event (MACE) rate was 1.1%. 30 day outcomes were favourable
with a MACE rate of 1.4%. The mortality rate was 0.2%, whilst unscheduled target
vessel revascularization rate was 0.5% (all stent thrombosis). Stroke occurred in 0.5%.
Conclusions: A hybrid approach to CTO-PCI is associated with high success rates
and low complications rates in the treatment of complex chronic total occlusion
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Background: We compared the in-hospital and the long-term clinical and angio-
graphic outcomes of the various intravascular ultrasound (IVUS) detected guidewire
(GW) induced coronary vessel injuries, following successful crossing of the CTO
segment between antegrade and retrograde approaches.
Methods: Two independent observers’ retrospectively analyzed all IVUS images of
173 CTO lesions (157 patients) successfully revascularized between August 2011 and
November 2012 in a high volume CTO center. IVUS detected GW induced coronary
vessel injuries were compared between the antegrade (113 lesions in 102 patients)
(Ante. group) and retrograde (60 lesions in 55 patients) (Retro. group) approaches, as
were the in-hospital and the long-term clinical and angiographic outcomes.
Results: IVUS showed that, in the Retro group, the GW more often tracked sub-
intimally, and induced dissections and coronary hematomas (p value for all was <
0.001)(Table), while the ﬁnal subintimal stenting was similar in both groups
(p¼0.47). Patients in the Retro group were likely to have an increased risk of peri-
procedural myocardial infarctions (p¼0.07), angiographic dissections (p< 0.001),
slow ﬂow (p¼0.02), and perforations (p¼0.02). There was no signiﬁcant difference
between the 2 groups regarding binary restenosis or target lesion revascularization
(p¼0.37, and p¼0.64, respectively). Five patients in the Retro group (9.4%) and one
in the Ante group (1%) died at one year (p¼0.02), mostly due to non-cardiac death.ronary Lesions - CTO B59
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(n¼113 lesions)
Retrograde
(n¼60 lesions) p value
Qualitative Findings:
Subintimal GW tracking, n
(%)*
18 (16) 33 (55) <0.001
Subintimal stenting, n (%) { 11 (9.7) 8 (13) 0.47
Dissection Flap, n (%) 39 (34.5) 42 (70) <0.001
Intramural Hematoma, n (%) 6 (5.3) 17 (28) <0.001
Calciﬁcation (%) 102 (90) 55 (92) 0.76
Calciﬁcation morphology
Superﬁcial (%) 67 (59) 38 (63) 0.6




12 (6 to 18) 17 (13 to 28) 0.01
Subintimal stenting length,
mm
13 (4 to 34) 12.6 (7 to 18) 0.93
Dissection length, mm 5.6 (4 to 9) 5.2 (3 to 9) 0.45
Maximum arc of calcium o 167 (110 to 239) 145 (96 to 194) 0.23
Proximal reference EEM
CSA, mm2
15.5  4.4 15.7  4.2 0.84
Proximal reference lumen
CSA, mm2
9.4  2.8 9.8  3.2 0.38
Distal reference-t EEM CSA,
mm2
8.4  3.4 7.6  2.9 0.15
Distal reference lumen CSA,
mm2
6  2 4.7  1.8 0.01
Post-Stent IVUS
measurements:
Mean stent CSA, mm2 7  1.9 6.7  1.9 0.47
Stent Expansion 0.86  0.33 0.91  0.27 0.34
Stent symmetry index 0.90  0.04 0.90  0.02 0.68
Values are n (%), mean  SD, or median (interquartile range). CSA ¼ cross-sectional area;
EEM ¼ external elastic membrane; GW¼ guidewire; IVUS ¼ intravascular ultrasound.
* immediately after wiring or after pre-dilation with a 1.5 to 2.0-mm balloon.{ ﬁnal guidewire
position in a false lumen with subsequent stent deployment in subintimal spaceConclusions: Intravascular ultrasound effectively differentiates between various GW
induced vessel injuries and depicts subintimal GW tracking. GW crossing with the
retrograde approach was associated with IVUS and angiographic coronary vessel
injuries, which increased the periprocedural complications. The long term clinical and
angiographic outcomes however, were comparable between the antegrade and retro-
grade approaches
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Background: The feasibility of using the BVS in chronic total occlusions (CTO)
lesions is unknown. This study sought to assess the safety, performance and efﬁcacy
of the Absorb everolimus-eluting bioresorbable vascular scaffold (BVS), in percuta-
neous CTO revascularization, under guidance of imaging techniques
Methods: 35 consecutive true CTOs lesions (Euro-CTO club deﬁnition) treated with
BVS were included in this prospective study. Target lesions were scaffold after
mandatory pre-dilatation and IVUS analysis. Optical coherence tomography (OCT)
study was performed after BVS implantation and at 12 months. A multi-slice
computed tomography (MSCT) was performed at baseline and at 6-8 months
Results: The mean age was 60.7  9.7 years old. 80% were male. 20% were diabetic
37% had a previous PCI. The most frequent lesions treated was the RCA (46%).
According to the Japanese-CTO score of complexity most of lesions were classiﬁed as
intermediate (49%) or difﬁcult-very difﬁcult (26%). 34% were moderate-severe
calciﬁed lesions. In most cases (86%) the strategy was antegrade. Pre-dilatation was
100% by cutting balloon in 71%. The total scaffold length implanted per lesion was ofB60 JACC Vol 64/11/Suppl B52.5  22.9mm. All the scaffolds were delivery and deployment successfully. Post-
dilatation was done in 63%. By OCT, ﬁnal minimum scaffold area and lumen stenosis
were of 7.1  1.5mm2 and 11.7  6.6%. There were no signiﬁcant areas of strut
malapposition. At a median of 10.2 (6.2-11.9) months, no MACE was reported and all
the devices were patent by MSCT. At 12-months angiographic follow-up with OCT
was completed in 16 patients, we observed one case of asymptomatic re-occlusion and
2 cases of signiﬁcant scaffold acquired malaposition.
Conclusions: BVS for CTO recanalization demonstrates excellent feasibility, safety
and long-term patency with no MACE at 10 months. At the time of the meeting
completed angiographic follow-up with OCT will be available
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Background: The “hybrid” approach to coronary chronic total occlusion (CTO)
crossing was developed to optimize procedural efﬁcacy, efﬁciency, and safety.
Methods: We examined the procedural techniques and outcomes of 639 consecutive
CTO percutaneous coronary interventions (PCI) performed using the “hybrid”
approach between 2012 and 2014 at 6 US centers.
Results: Mean age was 65  10 years and 86% of the patients were men, with high
prevalence of diabetes mellitus (42%) and prior coronary artery bypass graft surgery
(36%). Most target CTOs were located in the right coronary artery (59%), followed by
the left anterior descending artery (20%) and left circumﬂex (14%). Dual injection was
used in 74%. Overall, antegrade wire escalation was used in 65%, antegrade dissection/
re-entry in 38%, and the retrograde approach in 44%. Among successful cases, the ﬁnal
successful crossing technique was antegrade wire escalation in 42%, antegrade dissection
and re-entry in 27%, and retrograde in 31%. The initial crossing strategy was successful
in 60% of the patients, whereas 40% required an additional 1 to 4 crossing strategies.
Technical success was achieved in 92.6% and a major procedural complication occurred
in 1.7%. Median contrast volume, ﬂuoroscopy time, and air kerma radiation exposure
were 260 (190-360) ml, 42 (26-69) min, and 3.8 (2.2-5.8) Gray, respectively.
Conclusions: Application of the “hybrid” approach to CTO crossing resulted in high
success and low complication rates among a varied operator group and hospital
structure, supporting its expanding use in CTO PCI.
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Background: Although controlled antegrade and retrograde subintimal tracking
(CART) and reverse CART techniques improve the success rate of percutaneous
coronary intervention (PCI) for coronary chronic total occlusions (CTO), the safety
and efﬁcacy of these techniques have not yet been fully evaluated.
Methods: We studied 321 consecutive patients who were performed successful stent
implantation for de novo CTO lesion in our hospital between 2008 and 2013. After
excluding patients who were not performed follow-up coronary angiography after
PCI, ﬁnally 253 patients were examined. Patients were categorized as treated CTO
with CART or reverse CART technique group (CART group: n¼30) versus the
conventional treatment group (control group; n¼223). Angiographic and clinical
outcomes at 8-12 months were compared between the two groups.
Results: At baseline, the occlusion length was signiﬁcantly longer in patients in the
CART group (2117mm vs. 1310mm, p< 0.001) and the mean reference diameter
of the lesion was similar between the two groups (2.700.44mm vs. 2.810.48mm,
p¼0.33). The rate of complication including wire perforation or local dissection of the
coronary artery in the CART group was signiﬁcantly higher than the control group
(17% vs. 4%, p< 0.01). At the 8 to 12 months, there was no signiﬁcant differences in
the restenosis rate (13% vs 13%, p¼0.96). In addition, there was no statistical dif-
ferences between the two groups in angiographic parameters such as minimum lumen
diameter (2.380.86mm vs. 2.340.76mm, p¼0.85), percent diameter stenosis
(1927% vs. 1822%, p¼0.84) and late lumen loss (0.360.70mm vs
0.640.94mm, p¼0.11). During 8-month follow-up after PCI, no difference was
observed between the two groups in terms of major adverse cardiac events (MACEs)j September 13–17, 2014 j TCT Abstracts/Coronary Lesions - CTO
